Bluebird Bio Stock Investor Sentiment

BLUE Stock  USD 8.35  0.09  1.09%   
About 56% of all Bluebird Bio's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Bluebird bio suggests that some traders are interested. The current market sentiment, together with Bluebird Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Bluebird bio stock news signals to limit their universe of possible portfolio assets.
  

Bluebird Bio Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Bluebird Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at businesswire.com         
BLUE DIAMOND RESORTS SE UNE A LA RED DE INTERCAMBIOS DE INTERVAL CON SEIS PROPIEDADES DE CLASE MUNDI...
businesswire News
over three months ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS NAMED ONE OF TOP HEALTH PLANS IN COUNTRY FOR QUALITY AND EXP...
prnewswire News
over three months ago at finance.yahoo.com         
Blue Water Development Unites for Cancer Awareness with Blue Turns Pink Campaign
Yahoo News
over three months ago at finance.yahoo.com         
bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Fo...
Yahoo News
over three months ago at finance.yahoo.com         
Bluebird Q1 Earnings Snapshot
Yahoo News
over three months ago at prnewswire.com         
JOHNNIE WALKER BLENDED SCOTCH WHISKY TEAMS UP WITH EBON MOSS-BACHRACH, COURTNEY STORER AND CHARLES J...
prnewswire News
over three months ago at forbes.com         
Perrelet Introduces The Turbine Ice Blue Editions At Geneva Watch Days
Usa forbes News
over three months ago at news.google.com         
bluebird bio, Inc. Sees Significant Increase in Short Interest - MarketBeat
Google News at Macroaxis
over three months ago at finance.yahoo.com         
FDA will not meet ahead of bluebird bios sickle cell disease gene therapy PDUFA date
Yahoo News
over three months ago at finance.yahoo.com         
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
Yahoo News
over three months ago at techtimes.com         
Blue Origin New Glenn Launch Date ConfirmedHeres What to Expect For Debut Flight
news
over three months ago at businesswire.com         
bluebird bio Announces Receipt of Expected Notices from Nasdaq
businesswire News
over three months ago at seekingalpha.com         
bluebird bio announces receipt of notices from Nasdaq
seekingalpha News
over three months ago at news.google.com         
bluebird bio, Inc. Shares Acquired by Price T Rowe Associates Inc. MD - Defense World
Google News at Macroaxis
over three months ago at gurufocus.com         
bluebird bio Inc Q2 2024 Earnings Call Transcript Highlights Strong Revenue Growth and ...
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Bluebird Bio that are available to investors today. That information is available publicly through Bluebird media outlets and privately through word of mouth or via Bluebird internal channels. However, regardless of the origin, that massive amount of Bluebird data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bluebird Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bluebird Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bluebird Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bluebird Bio alpha.

Bluebird Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
OSCAR-NOMINATED NARRATIVE SHORT FILM RED, WHITE AND BLUE PREMIERING TODAY FOR FREE ON YOUTUBE THROUGH ELECTION WEEK
10/28/2024
2
Earnings call Bluebird bio sees patient growth, aims for 2025 breakeven
11/14/2024
3
THE DISTINCT COBALT BLUE OF SARATOGA SPRING WATER NOW HAS AN OFFICIAL PANTONE COLOR SARATOGA SIGNATURE BLUE, COLOR 286 C
12/02/2024
4
Disposition of 2824 shares by Colvin Richard A of Bluebird Bio at 0.4173 subject to Rule 16b-3
12/10/2024
5
Glass Lewis Joins ISS in Recommending Dye Durham Shareholders Vote Engine Capitals BLUE Proxy Card FOR Meaningful Boardroom Change at Dye Durham
12/12/2024
6
bluebird bio, Inc. Receives Average Recommendation of Hold from Brokerages - MarketBeat
12/18/2024
7
Once high-flying, bluebird bio now faces an uncertain future
12/26/2024
8
Disposition of 140 shares by Andrew Obenshain of Bluebird Bio at 9.24 subject to Rule 16b-3
01/06/2025
9
Disposition of 4526 shares by Krawtschuk Christopher of Bluebird Bio at 4.5155 subject to Rule 16b-3
01/10/2025
10
bluebird bio, Inc. Receives Average Rating of Hold from Analysts
01/17/2025

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets